Elcatonin

Renal impairment; heart failure; child (short-term treatment only and monitor bone growth); lactation; skin test prior to administration.

GI disturbances; tingling of the hands; skin rash; unpleasant taste; inflammatory reactions at Inj site; urinary frequency; tremor; transient hypocalcaemia (parenteral).

Cardiac glycosides.

Description:
Mechanism of Action: Elcatonin, a synthetic analogue of eel calcitonin, inhibits osteoclastic bone resorption. It is used in the treatment of diseases characterized by high bone turnover eg, Paget's disease of bone and as an adjunct in the treatment of severe hypercalcaemia.

Thuốc ảnh hưởng chuyển hóa xương